Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden |
Uganda |
HIV/AIDS, Tuberculosis |
|
|
Training in HIV Translational Research |
United States |
HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education |
|
|
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) |
United States |
HIV/AIDS |
|
|
SFBay CTU |
United States |
HIV/AIDS, Pharmacology and Drug Treatment |
|
|
ACTG, AIDS Clinical Trial Research Group |
Kenya; Malawi; Uganda; Zimbabwe; Botswana; South Africa; China; India; Thailand; Brazil; Peru; Haiti |
HIV/AIDS, Opportunistic Infection |
|
|
Sustainable East Africa Research in Community Health (SEARCH) |
Kenya; Uganda |
HIV/AIDS, Infectious Disease, Noncommunicable and/or Chronic Disease, Health Economics and Effectiveness, Access or Barriers to Care |
|
|
Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN) |
Kenya; Uganda |
HIV/AIDS, Adolescent Health |
|
|
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) |
Uganda |
HIV/AIDS, Malaria, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health |
|
|
Sustainable East Africa Research in Community Health |
Kenya; Uganda |
HIV/AIDS, Epidemiology and Surveillance, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training |
|
|
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) |
United States |
HIV/AIDS, Cardiovascular Disease |
|
|
Getting to Zero Coordinator/ SFPHF |
United States |
HIV/AIDS |
|
|
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding) |
United States |
HIV/AIDS |
|
|
SEARCH/AIDS Clinical Trial Research Group |
Uganda |
HIV/AIDS |
|
|
AIDS Clinical Trials Group; Protocol Funds |
United States |
HIV/AIDS |
|
|
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa |
Uganda |
HIV/AIDS, Malaria, Women's Health, Pediatrics |
|
|
Effect of Pitavastatin on Kidney Function in HIV-infected Persons |
United States |
HIV/AIDS, Cardiovascular Disease |
|
|
ACTG A5335s Specialty Lab |
United States |
Drug and Diagnostics Development, Immunology, Genetics |
|
|
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study |
United States |
HIV/AIDS, Cardiovascular Disease |
|
|
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates |
Kenya; Uganda |
HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes |
|
|
Reducing Failure-to-Initiate ART: Streamlined ART Start |
Uganda |
HIV/AIDS, Access or Barriers to Care, Implementation and Behavioral Science, Engagement in Care |
|
|
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 |
United States |
HIV/AIDS, Pharmacology and Drug Treatment |
|
|
Heals Endowment Fund at the East Bay Community Foundation |
United States |
HIV/AIDS |
|
|
Training in HIV Translational Research |
United States |
Training and Capacity Building |
|
|
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START) |
Uganda |
HIV/AIDS |
|
|
Therapeutic Strategies for HIV Disease |
Uganda |
HIV/AIDS |
|
|
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) |
Uganda |
HIV/AIDS, Malaria |
|
|
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1 |
Uganda |
HIV/AIDS, Pharmacology and Drug Treatment |
|
|
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II) |
Uganda |
HIV/AIDS |
|
|
UCSF HIV Clinical Trials Unit |
United States |
HIV/AIDS |
|
|
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services |
United States |
HIV/AIDS, Tuberculosis |
|
|
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects |
United States |
HIV/AIDS, Tuberculosis |
|
|
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 |
Uganda |
HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health |
|
|
Productive and Latent HIV Infection in Gut Mucosal Reservoirs |
United States |
HIV/AIDS |
|
|
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) |
Uganda |
HIV/AIDS, Malaria |
|
|
AIDS Research and Services at SF General Hospital |
United States |
HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention |
|
|
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) |
United States |
HIV/AIDS |
|
|
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257) |
Puerto Rico |
HIV/AIDS, Pharmacology and Drug Treatment |
|
|
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s) |
United States |
HIV/AIDS |
|
|
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) |
United States |
HIV/AIDS, Pharmacology and Drug Treatment |
|
|
Task Order Agreement No. CRB-DCR01-S-09-00325 |
United States |
Drug and Diagnostics Development |
|
|
Neurological AIDS Research Consortium |
United States |
HIV/AIDS |
|
|
AIDS Research and Services at SFGH |
United States |
HIV/AIDS |
|
|
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load |
Haiti |
HIV/AIDS |
|
|
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects |
United States |
HIV/AIDS, Tuberculosis |
|
|
AIDS Clinical Trials Group (ACTG) TTSG Services |
United States |
HIV/AIDS |
|
|
AIDS Clinical Trials Group (ACTG) Community Health Promoter |
Uganda |
HIV/AIDS |
|
|
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites |
Kenya; Uganda; Tanzania; Zimbabwe; South Africa; Ivory Coast |
HIV/AIDS, Pediatrics |
|
|
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position |
United States |
HIV/AIDS |
|
|
Task Order # 9: Supplement to SSS A5272 |
United States |
HIV/AIDS, Pharmacology and Drug Treatment |
|
|
Task Order Supplement to A5267 |
United States |
HIV/AIDS, Tuberculosis, Pharmacology and Drug Treatment |
|
|
Task Order # 6: Supplement to SSS A5257 |
United States |
HIV/AIDS |
|
|
Task Order # 7: Supplement to SSS A5254 |
United States |
HIV/AIDS, Opportunistic Infection, Oral Health |
|
|
Clinical Studies of Interactions Between HIV and Malaria |
Uganda |
HIV/AIDS, Malaria |
|
|
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A |
United States |
Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment |
|
|
Training in HIV Translational Research |
United States |
HIV/AIDS, Training and Capacity Building |
|
|
HIV/TB in Uganda: Punctuated Antiretroviral Therapy |
Uganda; South Africa |
HIV/AIDS, Tuberculosis |
|
|
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites |
Uganda |
HIV/AIDS, Engagement in Care, Health Systems Strengthening, Training and Capacity Building |
|
|
HIV/TB in Uganda: Punctuated Antiretroviral Therapy |
Uganda; South Africa |
HIV/AIDS, Tuberculosis |
|
|
Training in HIV Primary Care - Uganda Clinicians |
Uganda |
HIV/AIDS, Training and Capacity Building |
|
|
Therapeutic Strategies for HIV Disease |
Uganda |
HIV/AIDS |
|
|
Adult AIDS Clinical Trials Unit (AACTU) |
United States |
HIV/AIDS |
|
|
UCSF HIV/AIDS Management Training Programs |
United States |
HIV/AIDS, Training and Capacity Building |
|
|
International AIDS Research and Prevention |
Uganda |
HIV/AIDS |
|
|